Aptamer Group plc, a developer of synthetic oligonucleotide-based binding reagents for life sciences applications, and ...
The “2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage” replaces the 2012 “Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage.” The 2023 guideline ...